Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
Nefrologia (Engl Ed). 2020 Nov-Dec;40(6):675-676.
doi: 10.1016/j.nefro.2019.11.005.
Epub 2020 Jan 11.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Nephrology, Hospital Santa Cruz - Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal. Electronic address: arrcalca@gmail.com.
- 2 Department of Nephrology, Hospital Santa Cruz - Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
- 3 Department of Gastroenterology, Hospital Egas Moniz - Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
No abstract available
MeSH terms
-
Aged
-
Antiviral Agents / therapeutic use*
-
Benzimidazoles / therapeutic use*
-
Bone Neoplasms / diagnostic imaging
-
Bone Neoplasms / secondary
-
Carcinoma, Hepatocellular / diagnostic imaging
-
Carcinoma, Hepatocellular / etiology*
-
Carcinoma, Hepatocellular / secondary
-
Fatal Outcome
-
Female
-
Fluorenes / therapeutic use*
-
Hepacivirus
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Immunosuppression Therapy
-
Kidney Transplantation
-
Liver Neoplasms / diagnostic imaging
-
Liver Neoplasms / etiology*
-
Male
-
Renal Insufficiency, Chronic / surgery
-
Ribavirin / therapeutic use*
-
Sofosbuvir / therapeutic use*
-
Transplant Recipients
-
alpha-Fetoproteins / analysis
Substances
-
Antiviral Agents
-
Benzimidazoles
-
Fluorenes
-
alpha-Fetoproteins
-
ledipasvir, sofosbuvir drug combination
-
Ribavirin
-
Sofosbuvir